Ensysce Biosciences Inc.

NASDAQ: ENSC · Real-Time Price · USD
2.08
0.02 (0.97%)
At close: Aug 15, 2025, 3:59 PM
2.09
0.64%
After-hours: Aug 15, 2025, 05:36 PM EDT

Ensysce Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-6.58M -6.82M -7.99M -7.93M -11.28M -11.55M -10.63M -12.6M -19.76M -25.45M -24.21M -28.77M -36.11M -29.19M -29.15M -19.09M -340.46K -47.34K
Depreciation & Amortization
n/a 25.73K 1.2M 1.52M 1.52M 1.5M 326.15K n/a n/a n/a n/a -151 -101 -51 n/a 203.00 202.00 202.00
Stock-Based Compensation
253.98K 123.61K 110.72K 709.51K 744.37K 795.23K 879.16K 466.91K 568.38K 786.54K 1.07M 871.9K 739.58K 480.38K 121.76K 163.64K 190.32K 190.01K
Other Working Capital
-1.13M -888.03K -1.93M -4.77M -460.13K -1.28M 287.21K 2.6M 3.05M 3.88M 2.84M 137.14K 772.55K 365.39K 120K 2.21M 242.77K -851.37K
Other Non-Cash Items
-1.11M 18.59K 27.56K 492.04K 484.76K 447.09K 64.78K -1.2M 2.36M 3.25M -233.42K 6.2M 3.23M 3.29M 7.59M 2.19M 1.82M 2.44M
Deferred Income Tax
n/a n/a n/a -476.71K -476.71K -476.71K -476.71K n/a n/a n/a n/a 2.38M 14.93M 14.56M 14.5M 10.76M -3.96M -3.59M
Change in Working Capital
1.23M 846.38K -851.25K -2.86M -779.13K -1.29M -947.08K 1.06M 110.27K 3.35M 5.48M 950.8K 1.75M -307.4K -1.3M 976.71K 947.45K -446.99K
Operating Cash Flow
-6.2M -5.8M -7.5M -8.54M -9.78M -10.58M -10.78M -12.27M -16.73M -18.06M -17.89M -18.36M -15.47M -11.16M -8.24M -5.01M -1.34M -1.46M
Capital Expenditures
-4 -4 -1 -6 -6 -6 -9 -4 n/a n/a n/a n/a n/a n/a n/a 3.69K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.5K 4.5K 4.5K 4.5K n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 62.5K n/a n/a n/a -62.5K
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a 4.5K 4.5K 4.5K 9K 4.5K 4.5K 4.5K -62.5K 48.72M 48.72M 48.72M
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a 4.5K 4.5K 4.5K 9K 4.5K 4.5K 67K n/a 3.69K n/a -62.5K
Debt Repayment
-214.84K -266.07K -857.72K 844.18K 813.08K 279.45K 502.97K -2.25M 5.39M 5.71M 6.13M 16.25M 12.75M 13.06M 13.41M 4.43M 700K 1.25M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a -290 -4.92K -4.92K -4.92K -4.63K n/a n/a n/a -715.58K -715.58K -715.58K -715.58K n/a n/a n/a n/a
Other Financial Acitivies
6.13M 4.27M 3.95M 1.93M -605.11K -858.95K -792.46K -1.35M -1.4M -1.15M -1.14M -235.4K -379.65K 7.42M 8.08M 8.1M 8.29M 487.88K
Financial Cash Flow
7.37M 5.45M 9.88M 11.23M 7M 12.57M 8.76M 9.24M 16.82M 11.03M 8.77M 16.01M 11.19M 19.31M 20.31M 10.96M 8.6M 1.34M
Net Cash Flow
1.17M -351.86K 2.38M 2.69M -2.79M 1.99M -2.02M -3.04M 94.84K -7.03M -9.12M -2.34M -4.28M 8.15M 12.07M 6.12M 7.43M 51.81K
Free Cash Flow
-6.2M -5.8M -7.5M -8.54M -9.78M -10.58M -10.78M -12.27M -16.73M -18.06M -17.89M -18.36M -15.47M -11.16M -8.24M -5M -1.34M -1.46M